FSTRX
Price
$30.51
Change
-$0.87 (-2.77%)
Updated
Dec 18 closing price
VIVAX
Price
$65.90
Change
-$1.71 (-2.53%)
Updated
Dec 18 closing price
Ad is loading...

FSTRX vs VIVAX

Header iconFSTRX vs VIVAX Comparison
Open Charts FSTRX vs VIVAXBanner chart's image
Federated Hermes MDT Large Cap Value A
Price$30.51
Change-$0.87 (-2.77%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$65.90
Change-$1.71 (-2.53%)
VolumeN/A
CapitalizationN/A
FSTRX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSTRX vs. VIVAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTRX is a Hold and VIVAX is a Hold.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. FSTRX (1.33B). VIVAX pays higher dividends than FSTRX: VIVAX (2.25) vs FSTRX (1.08). FSTRX was incepted earlier than VIVAX: FSTRX (11 years) vs VIVAX (32 years). FSTRX is a more actively managed with annual turnover of: 95.00 vs. VIVAX (10.00). FSTRX has a lower initial minimum investment than VIVAX: FSTRX (1500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 16.42 vs. FSTRX (11.12). VIVAX return over 5 years is better than : 44.64 vs. FSTRX (20.00).
FSTRXVIVAXFSTRX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years32 years-
Gain YTD9.85216.00862%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B195B1%
Annual Yield % from dividends1.082.2548%
Returns for 1 year11.1216.4268%
Returns for 3 years7.5320.4837%
Returns for 5 years20.0044.6445%
Returns for 10 years23.46104.8222%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS31.130.19
+0.61%
ATS Corp
EVRI13.500.04
+0.30%
Everi Holdings
NTRS104.71-0.85
-0.81%
Northern Trust Corp
GLYC0.23-0.01
-2.83%
GlycoMimetics
LYEL0.65-0.02
-3.65%
Lyell Immunopharma